BlueView

Preventative maintenance and equipment service are ongoing topics of discussion in clinical settings. However, there is still a high-level of variance in how facilities prioritize and manage these activities. 

We sat down with Wes Peik, Director of Global Technical Services, at...

During the last three years, the primary focus in the vaccine market has been the development, distribution, and administration of COVID-19 vaccines. Since December 2020, more than 13.2 billion vaccine doses have been administered. Roughly 70 percent of the global population...

It’s been nearly three years since the first confirmed case of COVID-19 in the United States. Since then, the country has seen nearly one hundred million confirmed cases and more than one million fatalities due to the virus. 

Since the implementation of COVID-19 vaccines in...

As we approach the end of the year, the Helmer Scientific team took an opportunity to look back at the blogs from this year. We have compiled a list of the top 10 pharmacy and vaccine-related posts from 2022.

Topics include updated regulatory requirements, ongoing support for...

The first COVID-19 vaccine, the Pfizer-BioNTech COVID-19 vaccine, was approved for emergency use on December 11, 2020, in adults 16 and older.  

Since the first emergency use authorization was issued, the FDA has authorized the use of vaccines from three additional...

Since initially approved for emergency use in late 2020, COVID-19 vaccinations have proven to be the best weapon in the fight against COVID-19. Since the pandemic began, there have been nearly 95 million COVID-19 cases in the United States. 

The World Health Organization and UNICEF have released data showing a continued decline in vaccination rates among children. In 2021, 25 million infants worldwide did not receive one or more doses of routine immunizations. This represents the largest sustained decline in...

In the midst of a summer surge of COVID-19 cases in the United States, the FDA has approved the vaccine developed by Novavax for emergency use. The CDC has endorsed the use of this vaccine as a primary dose for people older than 18. 

The COVID-19 pandemic and subsequent mass-vaccination efforts have placed an increased emphasis (and increased accountability) on the proper storage and handling of refrigerated and frozen vaccines. Improper vaccine storage presents a significant risk to patient safety and...

Temperature monitoring for vaccine storage is important. Vaccine inventories exposed to temperature excursions represent a risk to public health, and patient safety and vaccine efficacy may be impacted if vaccines are stored outside the manufacturer’s recommended temperature...